As the immune system weakens with age, researchers have found a way to temporarily boost its function by reprogramming liver cells to support T-cell development.
NPR's Rob Stein explains why covering vaccines is no longer routine science journalism, but a political battleground.
The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership ...
Months of uncertainty have come to a close. The BIOSECURE Act, now part of the National Defense Authorization Act (NDAA), will put in motion US government-wide restrictions on ‘biotechnology companies ...
A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...
Since he entered politics, President Donald Trump has been a regular on our end-of-year list of the most egregious and ...
The co-founder of SCIMaP looks at the year of NIH cuts — and what they say about the future of American research.
Bird flu, particularly H5N1, is spreading through animals, raising pandemic concerns. While human infections are rare and ...
A newly revealed molecular tug-of-war may have implications for better understanding how a multitude of diseases and ...
A newly revealed molecular tug-of-war may have implications for better understanding how a multitude of diseases and ...
Researchers at the Icahn School of Medicine at Mount Sinai have developed a first-of-its-kind mRNA system that switches on therapeutic genes preferentially inside targeted cells-an advance ...
SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback